Physical Activity Intervention for Lung Cancer Survivors
1 other identifier
observational
52
1 country
1
Brief Summary
The purpose of this study is to learn how many lung cancer survivors will agree to a physical activity program. We also want to know if lung cancer survivors benefit from this program. This information will help us to develop our services for lung cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2008
CompletedFirst Submitted
Initial submission to the registry
July 16, 2008
CompletedFirst Posted
Study publicly available on registry
July 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2023
CompletedJune 7, 2023
June 1, 2023
15 years
July 16, 2008
June 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the feasibility (acceptability, adherence, treatment integrity, retention, participant satisfaction) of implementing a physical activity intervention trial among sedentary and insufficiently active lung cancer survivors.
conclusion of the study
Secondary Outcomes (2)
Obtain preliminary data on effect of a physical activity intervention on functional ability, health-related QOL, dyspnea, fatigue, balance, strength & self-report physical activity among sedentary and insufficiently active lung cancer survivors
conclusion of the study
To obtain preliminary data on factors associated with feasibility using variables from Social Cognitive Theory and assess their relationship with treatment adherence and dropout.
conclusion of the study
Study Arms (2)
1
Arm 1 - Physical Activity intervention
2
Arm 2 - Wait-list control
Interventions
For Arm 1 participants in the Physical Activity intervention condition will be assessed at baseline, and postintervention Follow-up (at 12 weeks post baseline).
Participants in the control condition (Arm 2)will be assessed at baseline and 12 weeks post baseline (Follow-up). At this time, the PA intervention will be offered at no cost to the participants in the control condition. If the waitlist participant chooses to complete the PA intervention after the 12 week waitlist period, program satisfaction will be assessed after study completion.
Eligibility Criteria
In total, we will recruit and enroll a random sample of 70 lung cancer survivors who are at least one year post thoracic surgical resection and have no evidence of NSCLC or any other cancer at the time of study enrollment and not receiving any adjuvant treatment.
You may qualify if:
- Diagnosis and treatment at MSKCC of primary NSCLC; and/or pulmonary carcinoid;
- At least one year post thoracic surgical resection;
- Have no evidence of NSCLC or any other cancer at the time of study enrollment and not receiving any cancer treatment;
- Currently sedentary or insufficiently active, defined by the American College of Sports Medicine (ACSM) and the Centers for Disease Control and Prevention as less than a total of 150 minutes of at least moderate intensity PA per week;
- Able to complete a six-minute walk test (6MWT);
- Able to provide informed consent.
- FOCUS GROUP ONLY:
- Completed the Physical Activity program offered through this study (08067);
You may not qualify if:
- Presence of one of the following medical factors at screening:
- regular use of an ambulatory aid (cane or walker);
- resting oxygen saturation less than 88%;
- inability to walk due to severe arthritis or other musculoskeletal problems;
- a diagnosis of unstable angina in the previous 6 weeks;
- a heart attack, angioplasty or heart surgery in the previous 3 months;
- current heart rate \<50 or \>120 at rest; current uncontrolled hypertension;
- current significant valvular heart disease or decompensated congestive heart failure and
- patient reported pain of any origin that would preclude participation in the proposed PA intervention
- Evidence of significant medical cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in the intervention
- Self-reporting of greater than 60 minutes of vigorous activity per week or 150 minutes of moderate intensity PA per week.
- Patient resides at more than two hours travel distance from the Center
- Insufficient English fluency to complete evaluation tools.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- Fox Chase Cancer Centercollaborator
- University of Albertacollaborator
- Brown Universitycollaborator
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamie Ostroff, PhD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2008
First Posted
July 18, 2008
Study Start
June 10, 2008
Primary Completion
June 5, 2023
Study Completion
June 5, 2023
Last Updated
June 7, 2023
Record last verified: 2023-06